U.S. federal trademark · Serial No. 90885323 · Reg. No. 6844128
Global initiative funded by public and private investments to promote public awareness of the importance of prevention and the early detection of cervical cancer and to facilitate and increase access to cervical cancer screening, the human papilloma virus (HPV) vaccine for prevention of cervical cancer and treatment for those most vulnerable to developing cervical cancer, including among HIV-positive women in sub-Saharan Africa
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.